Joint-stock drug firm Savipharm on April 14 received a certificate of good manufacturing practice (Japan-GMP) from Japan's Ministry of Labour, Welfare and Health for its factory in Ho Chi Minh City's Tan Thuan Export and Processing Zone for the 2015-20 period.
The factory employs advanced technology, and Savipharm is among several drug firms in Vietnam managed by a modern supervisory control and data acquisition (SCADA) system, according to Chairman of the company Tran Tuu.
The certification will help the company boost exports. Its products have entered the markets of Japan and several ASEAN countries, but the volume is still modest.
"We'll make major investments from this year in building additional three workshops and a research and development centre in the zone where our current land has sufficient space for them," said the Chairman.
He also told Viet Nam News that he will look for foreign capital and that several multinational firms have shown interest in becoming partners.
He expects to achieve turnover of 1 trillion VND (45 million USD) in 2020, which will be an annual increase of 30 percent compared to current figures.-VNA
The factory employs advanced technology, and Savipharm is among several drug firms in Vietnam managed by a modern supervisory control and data acquisition (SCADA) system, according to Chairman of the company Tran Tuu.
The certification will help the company boost exports. Its products have entered the markets of Japan and several ASEAN countries, but the volume is still modest.
"We'll make major investments from this year in building additional three workshops and a research and development centre in the zone where our current land has sufficient space for them," said the Chairman.
He also told Viet Nam News that he will look for foreign capital and that several multinational firms have shown interest in becoming partners.
He expects to achieve turnover of 1 trillion VND (45 million USD) in 2020, which will be an annual increase of 30 percent compared to current figures.-VNA
